Washington University Medical Center — St Louis, Missouri

Public research footprint of Washington University Medical Center, compiled from the ClinicalTrials.gov public registry.

164

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Advanced Lung Non-Squamous Non-Small Cell Carcinoma · Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 · Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 · Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma

Recently updated registry entries

NCT00114101 — Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell… (Active Not Recruiting)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)
NCT03233711 — Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Washington University Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.